Prentiss Smith & Co’s Regenxbio RGNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-10,107
| Closed | -$181K | – | 72 |
|
|
2023
Q4 | $181K | Sell |
10,107
-1,133
| -10% | -$20.3K | 0.14% | 66 |
|
|
2023
Q3 | $185K | Buy |
+11,240
| New | +$185K | 0.14% | 64 |
|
|
2023
Q1 | – | Sell |
-9,431
| Closed | -$214K | – | 68 |
|
|
2022
Q4 | $214K | Sell |
9,431
-153
| -2% | -$3.47K | 0.19% | 59 |
|
|
2022
Q3 | $253K | Sell |
9,584
-125
| -1% | -$3.3K | 0.22% | 55 |
|
|
2022
Q2 | $240K | Sell |
9,709
-1,000
| -9% | -$24.7K | 0.19% | 61 |
|
|
2022
Q1 | $355K | Sell |
10,709
-180
| -2% | -$5.97K | 0.21% | 60 |
|
|
2021
Q4 | $356K | Sell |
10,889
-100
| -0.9% | -$3.27K | 0.17% | 67 |
|
|
2021
Q3 | $461K | Hold |
10,989
| – | – | 0.23% | 56 |
|
|
2021
Q2 | $427K | Sell |
10,989
-117
| -1% | -$4.55K | 0.21% | 61 |
|
|
2021
Q1 | $379K | Sell |
11,106
-670
| -6% | -$22.9K | 0.19% | 60 |
|
|
2020
Q4 | $534K | Sell |
11,776
-625
| -5% | -$28.3K | 0.25% | 53 |
|
|
2020
Q3 | $341K | Buy |
12,401
+18
| +0.1% | +$495 | 0.18% | 56 |
|
|
2020
Q2 | $456K | Buy |
12,383
+152
| +1% | +$5.6K | 0.28% | 44 |
|
|
2020
Q1 | $396K | Buy |
12,231
+200
| +2% | +$6.48K | 0.27% | 48 |
|
|
2019
Q4 | $493K | Buy |
12,031
+4,425
| +58% | +$181K | 0.32% | 44 |
|
|
2019
Q3 | $271K | Buy |
7,606
+56
| +0.7% | +$2K | 0.18% | 54 |
|
|
2019
Q2 | $388K | Buy |
+7,550
| New | +$388K | 0.25% | 53 |
|
|
2018
Q4 | – | Sell |
-670
| Closed | -$51K | – | 191 |
|
|
2018
Q3 | $51K | Hold |
670
| – | – | 0.03% | 117 |
|
|
2018
Q2 | $48K | Buy |
+670
| New | +$48K | 0.03% | 120 |
|